# Takeda's $11bn drug trio targets peak sales

> Takeda's new drugs could earn $11bn by 2027.
- Title: Takeda's $11bn drug trio targets peak sales · Nikkei Asia
- Summary: Takeda's new drugs could earn $11bn by 2027. Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year.
- Keywords: takeda, blockbuster drugs, peak sales, pharmaceuticals, drug trio, sales target, news, business, world, Takeda's, 11bn, drug
- Source: Nikkei Asia — https://asia.nikkei.com/business/pharmaceuticals/takeda-bets-on-blockbuster-drug-trio-to-generate-11bn-in-peak-sales
- Published: 2026-10-29T17:29:51+00:00
- Read time: 1 min
- Topics: takeda, blockbuster drugs, peak sales, pharmaceuticals, drug trio, sales target, news, business, world
## Takeda's drug trio
Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year.
## Stock price rise
Stock price rises to highest level in more than 8 years on expectations.
## Drug launches
Takeda releases three major drugs through next year.
## Key takeaway

Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year.